<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39347199</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Detection of SARS-CoV-2 Variants Imported Through Land Borders at the Height of the COVID-19 Pandemic in Ghana, 2022.</ArticleTitle><Pagination><StartPage>e68220</StartPage><MedlinePgn>e68220</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68220</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68220</ELocationID><Abstract><AbstractText>Background The World Health Organization recommends surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at points of entry to systematically collect and analyze data to inform decisions about the effective and appropriate use of resources needed for interventions. This study sought to determine the prevalence of SARS-CoV-2 and its variants imported into Ghana by travelers entering the country via land borders from February to July 2022. Methods A cross-sectional approach was employed, where recruited participants consented to the collection of oropharyngeal and nasopharyngeal samples. Specimens were analyzed for the presence of SARS-CoV-2 ribonucleic acid (RNA) using a commercially available VeriQ nCoV-OM COVID-19 Multiplex Detection kit. Amplicon sequencing protocols (ARTIC network, Oxford Nanopore Technologies (ONT), New England Biolabs, British Columbia Centre for Disease Control (BCCDC), COVID-19 Genomics UK (COG-UK), Canadian COVID-19 Genomics Network (CanCOGen), and ONT MinION) were used for SARS-CoV-2 sequencing. Logistic regression and phylogenetic analyses were conducted on the generated data. Results We detected a SARS-CoV-2 prevalence of 3.6% (170/4,621) among a total of 4,621 travelers screened. The average age of travelers was 32.11 ± 11.77, with the majority being male (68%, 3,132/4,621). After adjusting for educational status, household size, vaccination status, and study site, those with primary and tertiary education levels had 1.74 (95% CI: 1.16-2.62, P = 0.007) and 2.27 (95% CI: 1.27-4.05, P = 0.006) higher odds of testing positive for SARS-CoV-2 compared to those with no education. Vaccinated travelers had 0.65 odds (95% CI: 0.48-0.89, P = 0.007) of testing positive for SARS-CoV-2. The Omicron variant (B.1.1.529) emerged as the predominant lineage, constituting 77% (27/35) of isolates, compared to Alpha, Delta, and Recombinant variants. Phylogenetic analysis corroborated this finding, highlighting Delta and Omicron as the dominant circulating SARS-CoV-2 variants. Notably, Ghanaian strains from this study clustered with global variants, suggesting multiple introductions, likely through land borders. Conclusion A low prevalence of SARS-CoV-2 was recorded in this study, prompting the decision to reopen land borders and ease pandemic-related travel restrictions. Omicron was identified as the dominant variant. These findings emphasize the crucial role of routine surveillance at port health and advocate for a collaborative approach to addressing public health crises, preventing unnecessary travel and trade restrictions through data-based decision-making.</AbstractText><CopyrightInformation>Copyright © 2024, Asante et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asante</LastName><ForeName>Ivy A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lwanga</LastName><ForeName>Charles N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takyi</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekyi-Yorke</LastName><ForeName>Ama N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quarcoo</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odikro</LastName><ForeName>Magdalene A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kploanyi</LastName><ForeName>Emma E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donkor</LastName><ForeName>Irene O</ForeName><Initials>IO</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addo-Lartey</LastName><ForeName>Adolphina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duah</LastName><ForeName>Nyarko A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odumang</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomotey</LastName><ForeName>Elvis S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boatemaa</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwasah</LastName><ForeName>Lorreta</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyarko</LastName><ForeName>Stephen O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Affram</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&amp;M University, College Station, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asiedu-Bekoe</LastName><ForeName>Franklin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Public Health Division, Ghana Health Service, Accra, GHA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenu</LastName><ForeName>Ernest</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Ghana, Accra, GHA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ghana</Keyword><Keyword MajorTopicYN="N">land borders</Keyword><Keyword MajorTopicYN="N">phylogeny</Keyword><Keyword MajorTopicYN="N">sars-cov-2</Keyword><Keyword MajorTopicYN="N">variants</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Ghana Health Service Ethical Review Committee issued approval GHS-ERC:017/01/22. Approval for the study was obtained from the Ghana Health Service Ethics Review Committee (GHS-ERC:017/01/22) and the Noguchi Memorial Institute for Medical Research Institutional Review Board (NMIMR-IRB CPN 017/21-22). The participants provided written informed consent before participating in the study. The data collected was devoid of personal identifiers. Swabs collected from travelers were used only for research purposes. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: This research was funded by the Ghana Health Service through the C19RM Wave 1 funding from the Global Fund. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39347199</ArticleId><ArticleId IdType="pmc">PMC11439440</ArticleId><ArticleId IdType="doi">10.7759/cureus.68220</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mutations and phylogenetic analyses of SARS-CoV-2 among imported COVID-19 from abroad in Nanjing, China. Zhao N, Zhou N, Fan H, et al. Front Microbiol. 2022;13:851323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8969601</ArticleId><ArticleId IdType="pubmed">35369437</ArticleId></ArticleIdList></Reference><Reference><Citation>Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins. Hossain MU, Ahammad I, Bhattacharjee A, et al. RSC Adv. 2021;11:38868–38879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9044322</ArticleId><ArticleId IdType="pubmed">35493250</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020.  [
Oct;
2022 
]. 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020</Citation></Reference><Reference><Citation>The COVID-19 situation in Ghana.  [
Oct;
2022 
]. 2021. http://rstmh.org/news-blog/news/the-covid-19-situation-in-ghana http://rstmh.org/news-blog/news/the-covid-19-situation-in-ghana</Citation></Reference><Reference><Citation>COVID19 cases.  [
Nov;
2022 
]. 2020. http://who.maps.arcgis.com/apps/dashboards/0c9b3a8b68d0437a8cf28581e9c063a9 http://who.maps.arcgis.com/apps/dashboards/0c9b3a8b68d0437a8cf28581e9c063a9</Citation></Reference><Reference><Citation>Ghana Ghana. Ghana: Ministry of Health confirms first case of COVID-19 March 13 | Crisis24.  [
Oct;
2022 
]. 2020. https://crisis24.garda.com/alerts/2020/03/ghana-ministry-of-health-confirms-first-case-of-covid-19-march-13 https://crisis24.garda.com/alerts/2020/03/ghana-ministry-of-health-confirms-first-case-of-covid-19-march-13</Citation></Reference><Reference><Citation>Responding to the COVID-19 pandemic in Ghana. Kenu E, Frimpong JA, Koram KA. Ghana Med J. 2020;54:72–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7829051</ArticleId><ArticleId IdType="pubmed">33536675</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview of preparedness and response to COVID-19 in Ghana. Sarkodie B, Asiedu-Bekoe F, Laryea DO, et al. Ghana Med J. 2021;55:38–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853692</ArticleId><ArticleId IdType="pubmed">35233113</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID19 cases .  [
Nov;
2022 
]. 2022. https://who.maps.arcgis.com/apps/dashboards/0c9b3a8b68d0437a8cf28581e9c063a9 https://who.maps.arcgis.com/apps/dashboards/0c9b3a8b68d0437a8cf28581e9c063a9</Citation></Reference><Reference><Citation>Transmission dynamics of COVID-19 in Ghana and the impact of public health interventions. Ofori SK, Schwind JS, Sullivan KL, et al. Am J Trop Med Hyg . 2022;107:175–179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9294683</ArticleId><ArticleId IdType="pubmed">35605636</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare in Ghana amidst the coronavirus pandemic: a narrative literature review. Dzando G, Salifu S, Donyi AB, Akpeke H, Kumah A, Dordunu R, Nonoh EA. J Public Health Res. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847958</ArticleId><ArticleId IdType="pubmed">34351103</ArticleId></ArticleIdList></Reference><Reference><Citation>Maintaining essential health services during COVID-19 in Ghana: a qualitative study. Yeboah I, Dwomoh D, Ndejjo R, et al. BMJ Glob Health. 2024;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11148662</ArticleId><ArticleId IdType="pubmed">38490688</ArticleId></ArticleIdList></Reference><Reference><Citation>Africanews: “Forty-four countries sign historic African Union free trade agreement”.  [
Nov;
2022 
]. 2018. http://www.africanews.com/2018/03/21/forty-four-countries-sign-historic-africa-union-free-trade-agreement// http://www.africanews.com/2018/03/21/forty-four-countries-sign-historic-africa-union-free-trade-agreement//</Citation></Reference><Reference><Citation>Ghana: Intra-Africa trade and tariff profile.  [
Aug;
2024 
]. 2018. https://www.tralac.org/documents/publications/trade-data-analysis/2691-ghana-intra-africa-trade-and-tariff-profile-november-2018/file. https://www.tralac.org/documents/publications/trade-data-analysis/2691-ghana-intra-africa-trade-and-tariff-profile-november-2018/file.</Citation></Reference><Reference><Citation>Ghana: Government risks re-opening land borders as economy tumbles.  [
Aug;
2024 
]. 2022. https://www.theafricareport.com/186413/ghana-government-risks-re-opening-land-borders-as-economy-tumbles/ https://www.theafricareport.com/186413/ghana-government-risks-re-opening-land-borders-as-economy-tumbles/</Citation></Reference><Reference><Citation>Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021. Morang'a CM, Ngoi JM, Gyamfi J, et al. Nat Commun. 2022;13:2494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9076825</ArticleId><ArticleId IdType="pubmed">35523782</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana. Ngoi JM, Quashie PK, Morang'a CM, et al. Exp Biol Med (Maywood) 2021;246:960–970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746953</ArticleId><ArticleId IdType="pubmed">33325750</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghana Ghana. Ghana: Administrative Division (Regions and Districts); [ Nov; 2022 ]. 2022. Ghana: Administrative division (regions and districts) - population statistics, charts and map.</Citation></Reference><Reference><Citation>COVID-19 updates: Ghana.  [
Mar;
2024 
]. https://ghs.gov.gh/covid19/ https://ghs.gov.gh/covid19/</Citation></Reference><Reference><Citation>COVID-19 cases: WHO COVID-19 dashboard.  [
Mar;
2024 
]. 2024. http://data.who.int/dashboards/covid19/cases?n=o http://data.who.int/dashboards/covid19/cases?n=o</Citation></Reference><Reference><Citation>COVID-19 amongst travelers at points of entry in Nepal: screening, testing, diagnosis and isolation practices. Subedee KC, Paudel KP, Khogali M, et al. Trop Med Infect Dis. 2022;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9230935</ArticleId><ArticleId IdType="pubmed">35736978</ArticleId></ArticleIdList></Reference><Reference><Citation>Retrospective overview of a COVID-19 outbreak in Mauritania. El Vally A, Bollahi MA, Ould Ahmedou Salem MS, et al. New Microbes New Infect. 2020;38:100788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560268</ArticleId><ArticleId IdType="pubmed">33082959</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for SARS-CoV-2 infection severity in Abu Dhabi. Baynouna AlKetbi LM, Nagelkerke N, Abdelbaqi H, et al. J Epidemiol Glob Health. 2021;11:344–353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381146</ArticleId><ArticleId IdType="pubmed">34734381</ArticleId></ArticleIdList></Reference><Reference><Citation>Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Zhang J, Litvinova M, Liang Y, et al. Science. 2020;368:1481–1486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199529</ArticleId><ArticleId IdType="pubmed">32350060</ArticleId></ArticleIdList></Reference><Reference><Citation>On the effect of age on the transmission of SARS-CoV-2 in households, schools, and the community. Goldstein E, Lipsitch M, Cevik M. J Infect Dis. 2021;223:362–369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665686</ArticleId><ArticleId IdType="pubmed">33119738</ArticleId></ArticleIdList></Reference><Reference><Citation>Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Amorim Filho L, Szwarcwald CL, Mateos SO, et al. Rev Saude Publica. 2020;54:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334006</ArticleId><ArticleId IdType="pubmed">32638883</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Ward H, Atchison C, Whitaker M, et al. Nat Commun. 2021;12:905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876103</ArticleId><ArticleId IdType="pubmed">33568663</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 infections among asymptomatic individuals contributed to COVID-19 cases: A cross-sectional study among prospective air travelers from Ghana. Akowuah KA, Akuffo RA, Boateng AT, et al. Front Public Health. 2022;10:1035763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9795010</ArticleId><ArticleId IdType="pubmed">36589973</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission dynamics should inform policy. Cevik M, Marcus JL, Buckee C, Smith TC. Clin Infect Dis. 2021;73:0–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543342</ArticleId><ArticleId IdType="pubmed">32964919</ArticleId></ArticleIdList></Reference><Reference><Citation>High-poverty neighborhoods bear the brunt of Covid’s scourge - KFF Health News.  [
Mar;
2024 
]. 2020. http://kffhealthnews.org/news/article/high-poverty-neighborhoods-bear-the-brunt-of-covids-scourge/ http://kffhealthnews.org/news/article/high-poverty-neighborhoods-bear-the-brunt-of-covids-scourge/</Citation></Reference><Reference><Citation>Association of lower socioeconomic status and SARS-CoV-2 positivity in Los Angeles, California. Allan-Blitz LT, Goldbeck C, Hertlein F, Turner I, Klausner JD. J Prev Med Public Health. 2021;54:161–165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8190552</ArticleId><ArticleId IdType="pubmed">34092061</ArticleId></ArticleIdList></Reference><Reference><Citation>Behavioral factors associated with SARS-CoV-2 infection. Cajar MD, Tan FC, Boisen MK, et al. BMJ Open. 2022;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170796</ArticleId><ArticleId IdType="pubmed">36691250</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. Chi WY, Li YD, Huang HC, et al. J Biomed Sci. 2022;29:82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9569411</ArticleId><ArticleId IdType="pubmed">36243868</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission. Fisman DN, Amoako A, Tuite AR. CMAJ. 2022;194:0–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9054088</ArticleId><ArticleId IdType="pubmed">35470204</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine inequity undermining global economic recovery.  [
Mar;
2024 
]. 2021. http://www.who.int/news/item/22-07-2021-vaccine-inequity-undermining-global-economic-recovery http://www.who.int/news/item/22-07-2021-vaccine-inequity-undermining-global-economic-recovery</Citation></Reference><Reference><Citation>One Africa COVID-19 tracker - one data &amp; analysis.  [
Mar;
2024 
]. 2022. https://data.one.org/data-dives/covid-19-response/ https://data.one.org/data-dives/covid-19-response/</Citation></Reference><Reference><Citation>Vaccine hesitancy in Africa: causes and strategies to the rescue. Aborode AT, Fajemisin EA, Ekwebelem OC, et al. Ther Adv Vaccines Immunother. 2021;9:25151355211047514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8481750</ArticleId><ArticleId IdType="pubmed">34604696</ArticleId></ArticleIdList></Reference><Reference><Citation>Planning for COVID-19 vaccines safety surveillance. Kochhar S, Salmon DA. Vaccine. 2020;38:6194–6198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351416</ArticleId><ArticleId IdType="pubmed">32684499</ArticleId></ArticleIdList></Reference><Reference><Citation>Omicron's molecular structure could help explain its global takeover. Kwon D. Nature. 2022;602:373–374.</Citation><ArticleIdList><ArticleId IdType="pubmed">35115694</ArticleId></ArticleIdList></Reference><Reference><Citation>A novel data-driven methodology for influenza outbreak detection and prediction. Du L, Pang Y. Sci Rep. 2021;11:13275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8225876</ArticleId><ArticleId IdType="pubmed">34168200</ArticleId></ArticleIdList></Reference><Reference><Citation>Estimates of SARS-CoV-2 Omicron variant severity in Ontario, Canada. Ulloa AC, Buchan SA, Daneman N, Brown KA. JAMA. 2022;327:1286–1288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8855311</ArticleId><ArticleId IdType="pubmed">35175280</ArticleId></ArticleIdList></Reference><Reference><Citation>Omicron's feeble attack on the lungs could make it less dangerous. Kozlov M. Nature. 2022;601:177.</Citation><ArticleIdList><ArticleId IdType="pubmed">34987210</ArticleId></ArticleIdList></Reference><Reference><Citation>Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Veneti L, Bøås H, Bråthen Kristoffersen A, et al. Euro Surveill. 2022;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8796289</ArticleId><ArticleId IdType="pubmed">35086614</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022. Kahn F, Bonander C, Moghaddassi M, Rasmussen M, Malmqvist U, Inghammar M, Björk J. Euro Surveill. 2022;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8895467</ArticleId><ArticleId IdType="pubmed">35241215</ArticleId></ArticleIdList></Reference><Reference><Citation>Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Wolter N, Jassat W, Walaza S, et al. Lancet. 2022;399:437–446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>Population immunity and COVID-19 severity with Omicron variant in South Africa. Madhi SA, Kwatra G, Myers JE, et al. N Engl J Med. 2022;386:1314–1326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8908853</ArticleId><ArticleId IdType="pubmed">35196424</ArticleId></ArticleIdList></Reference><Reference><Citation>The Omicron variant of the SARS-CoV-2 virus as the dominant agent of a new risk of disease amid the COVID-19 pandemic. Onishchenko GG, Sizikova TE, Lebedev VN, Borisevich SV. Her Russ Acad Sci. 2022;92:381–391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9447973</ArticleId><ArticleId IdType="pubmed">36091850</ArticleId></ArticleIdList></Reference><Reference><Citation>Repurposing an integrated national influenza platform for genomic surveillance of SARS-CoV-2 in Ghana: a molecular epidemiological analysis. Asante IA, Hsu SN, Boatemaa L, et al. Lancet Glob Health. 2023;11:0–85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290548</ArticleId><ArticleId IdType="pubmed">37349034</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>